Graham Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.12M Buy
66,756
+14,592
+28% +$1.28M 0.11% 135
2026
Q1
$4.45M Buy
+52,164
New +$4.65M 0.11% 144
2024
Q4
Sell
-125,545
Closed -$13M 1261
2024
Q3
$13M Sell
125,545
-15,917
-11% -$1.62M 0.22% 61
2024
Q2
$13.7M Buy
+141,462
New +$13M 0.3% 39
2024
Q1
Sell
-55,203
Closed -$4.4M 1088
2023
Q4
$4.4M Buy
55,203
+50,327
+1,032% +$3.78M 0.1% 122
2023
Q3
$347K Sell
4,876
-35,613
-88% -$2.66M 0.01% 676
2023
Q2
$3.12M Buy
40,489
+36,129
+829% +$2.8M 0.09% 150
2023
Q1
$328K Sell
4,360
-3,697
-46% -$275K 0.01% 868
2022
Q4
$635K Buy
+8,057
New +$604K 0.02% 688

Other funds holding CL

Graham Capital Management's CL Position: Q2 2026 in Review

Graham Capital Management increased its Colgate-Palmolive (CL) stake by 28% in Q2 2026, buying an estimated $1.28M and bringing the position to 66,756 shares worth $6.12M. The position accounts for 0.11% of the portfolio, ranked #135.

Graham Capital Management first reported a position in CL in Q4 2022 and has held it in 9 quarters since. The position peaked at $13.7M in Q2 2024. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Graham Capital Management held 66,756 shares of Colgate-Palmolive worth $6.12M as of Q2 2026.
  • Graham Capital Management bought 14,592 Colgate-Palmolive shares in Q2 2026, an estimated $1.28M.
  • Colgate-Palmolive made up 0.11% of Graham Capital Management's portfolio in Q2 2026, its #135 holding.
  • Graham Capital Management first reported a position in Colgate-Palmolive in Q4 2022 and has held it in 9 quarters since.
  • Graham Capital Management's Colgate-Palmolive position peaked at $13.7M in Q2 2024.
  • 2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.